Patterns of Immune Dysregulation in Bipolar Disorder

Benney MR Argue,Lucas G Casten,Shaylah McCool,Aysheh Alrfooh,Jenny Gringer Richards,John A Wemmie,Vincent A Magnotta,Aislinn J Williams,Jake J Michaelson,Jess G Fiedorowicz,Sabrina M Scroggins,Marie Elizabeth Gaine

DOI: https://doi.org/10.1101/2024.07.26.24311078

2024-07-27

Abstract:Background: Bipolar disorder is a debilitating mood disorder associated with a high risk of suicide and characterized by immune dysregulation. In this study, we used a multi-faceted approach to better distinguish the pattern of dysregulation of immune profiles in individuals with BD. Methods: We analyzed peripheral blood mononuclear cells (bipolar disorder N=39, control N=30), serum cytokines (bipolar disorder N=86, control N=58), whole blood RNA (bipolar disorder N=25, control N=25), and whole blood DNA (bipolar disorder N=104, control N=66) to identify immune-related differences in participants diagnosed with bipolar disorder compared to controls. Results: Flow cytometry revealed a higher proportion of monocytes in participants with bipolar disorder together with a lower proportion of T helper cells. Additionally, the levels of 18 cytokines were significantly elevated, while two were reduced in participants with bipolar disorder. Most of the cytokines altered in individuals with bipolar disorder were proinflammatory. Forty-nine genes were differentially expressed in our bipolar disorder cohort and further analyses uncovered several immune-related pathways altered in these individuals. Genetic analysis indicated variants associated with inflammatory bowel disease also influences bipolar disorder risk. Discussion: Our findings indicate a significant immune component to bipolar disorder pathophysiology and genetic overlap with inflammatory bowel disease. This comprehensive study supports existing literature, whilst also highlighting novel immune targets altered in individuals with bipolar disorder. Specifically, multiple lines of evidence indicate differences in the peripheral representation of monocytes and T cells are hallmarks of bipolar disorder.

Psychiatry and Clinical Psychology

What problem does this paper attempt to address?

The paper attempts to address the issue of immune dysregulation in Bipolar Disorder (BD) and its underlying mechanisms. Specifically, the researchers used various experimental methods to better distinguish the immune characteristics between BD patients and healthy control groups. The main objectives of the paper are as follows:

1. **Changes in Immune Cell Proportions**: By analyzing peripheral blood mononuclear cells (PBMCs) through flow cytometry, it was found that the proportion of monocytes increased in BD patients, while the proportion of T helper cells decreased.

2. **Changes in Cytokine Levels**: By detecting the concentration of various cytokines in the serum, it was found that 18 cytokines were significantly elevated in BD patients, most of which were pro-inflammatory cytokines; meanwhile, 2 cytokines were reduced. These changes indicate an enhanced inflammatory response in BD patients.

3. **Differences in Gene Expression**: By sequencing whole blood RNA, it was found that 49 genes had significantly different expressions in BD patients. Further analysis revealed that multiple immune-related signaling pathways were affected.

4. **Genetic Association Analysis**: Through genotyping analysis, it was found that there is a genetic overlap between BD and inflammatory bowel disease (IBD), suggesting that certain genetic variations may simultaneously affect the risk of both BD and IBD.

Based on the above results, the researchers believe that there is a significant immune component in the pathophysiology of BD and propose several new immune targets. In particular, the differences in the proportions of monocytes and T cells in peripheral blood may be important markers of BD. Additionally, the study found that BD shares common genetic risk factors with certain autoimmune diseases. These findings help to better understand the pathogenesis of BD and provide new ideas for future treatments.